1
|
Li S, Li W, Jin Y, Wu B, Wu Y. Advancements in the development of nucleic acid vaccines for syphilis prevention and control. Hum Vaccin Immunother 2023; 19:2234790. [PMID: 37538024 PMCID: PMC10405752 DOI: 10.1080/21645515.2023.2234790] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2023] [Revised: 06/12/2023] [Accepted: 07/05/2023] [Indexed: 08/05/2023] Open
Abstract
Syphilis, a chronic systemic sexually transmitted disease, is caused by the bacterium Treponema pallidum (T. pallidum). Currently, syphilis remains a widespread infectious disease with significant disease burden in many countries. Despite the absence of identified penicillin-resistant strains, challenges in syphilis treatment persist due to penicillin allergies, supply issues, and the emergence of macrolide-resistant strains. Vaccines represent the most cost-effective strategy to prevent and control the syphilis epidemic. In light of the ongoing global coronavirus disease 2019 (COVID-19) pandemic, nucleic acid vaccines have gained prominence in the field of vaccine research and development, owing to their superior efficiency compared to traditional vaccines. This review summarizes the current state of the syphilis epidemic and the preliminary findings in T. pallidum nucleic acid vaccine research, discusses the challenges associated with the development of T. pallidum nucleic acid vaccines, and proposes strategies and measures for future T. pallidum vaccine development.
Collapse
Affiliation(s)
- Sijia Li
- Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang Medical College, Institution of Pathogenic Biology, University of South China, Hengyang, China
| | - Weiwei Li
- Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang Medical College, Institution of Pathogenic Biology, University of South China, Hengyang, China
- Department of Clinical Laboratory, The Second People’s Hospital of Foshan, Foshan, China
| | - Yinqi Jin
- Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang Medical College, Institution of Pathogenic Biology, University of South China, Hengyang, China
| | - Bin Wu
- First Affiliated Hospital, Guangdong Medical University, Zhanjiang, Guangdong, China
| | - Yimou Wu
- Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang Medical College, Institution of Pathogenic Biology, University of South China, Hengyang, China
| |
Collapse
|
2
|
Nguyen MH, Pham TTM, Pham LV, Phan DT, Tran TV, Nguyen HC, Nguyen HC, Ha TH, Dao HK, Nguyen PB, Trinh MV, Do TV, Nguyen HQ, Nguyen TTP, Nguyen NPT, Tran CQ, Tran KV, Duong TT, Nguyen TT, Pham KM, Nguyen LV, Vo TT, Do BN, Dang NH, Le TT, Do NT, Nguyen HTT, Mai TTT, Ha DT, Ngo HTM, Nguyen KT, Bai CH, Duong TV. Associations of Underlying Health Conditions With Anxiety and Depression Among Outpatients: Modification Effects of Suspected COVID-19 Symptoms, Health-Related and Preventive Behaviors. Int J Public Health 2021; 66:634904. [PMID: 34335139 PMCID: PMC8284590 DOI: 10.3389/ijph.2021.634904] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2020] [Accepted: 05/28/2021] [Indexed: 12/18/2022] Open
Abstract
Objectives: We explored the association of underlying health conditions (UHC) with depression and anxiety, and examined the modification effects of suspected COVID-19 symptoms (S-COVID-19-S), health-related behaviors (HB), and preventive behaviors (PB). Methods: A cross-sectional study was conducted on 8,291 outpatients aged 18–85 years, in 18 hospitals and health centers across Vietnam from 14th February to May 31, 2020. We collected the data regarding participant's characteristics, UHC, HB, PB, depression, and anxiety. Results: People with UHC had higher odds of depression (OR = 2.11; p < 0.001) and anxiety (OR = 2.86; p < 0.001) than those without UHC. The odds of depression and anxiety were significantly higher for those with UHC and S-COVID-19-S (p < 0.001); and were significantly lower for those had UHC and interacted with “unchanged/more” physical activity (p < 0.001), or “unchanged/more” drinking (p < 0.001 for only anxiety), or “unchanged/healthier” eating (p < 0.001), and high PB score (p < 0.001), as compared to those without UHC and without S-COVID-19-S, “never/stopped/less” physical activity, drinking, “less healthy” eating, and low PB score, respectively. Conclusion: S-COVID-19-S worsen psychological health in patients with UHC. Physical activity, drinking, healthier eating, and high PB score were protective factors.
Collapse
Affiliation(s)
- Minh H Nguyen
- International Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
| | - Thu T M Pham
- Faculty of Public Health, Hai Phong University of Medicine and Pharmacy, Hai Phong, Vietnam.,School of Public Health, College of Public Health, Taipei Medical University, Taipei, Taiwan
| | - Linh V Pham
- Department of Pulmonary and Cardiovascular Diseases, Hai Phong University of Medicine and Pharmacy Hospital, Hai Phong, Vietnam.,Director Office, Hai Phong University of Medicine and Pharmacy Hospital, Hai Phong, Vietnam
| | - Dung T Phan
- Faculty of Nursing, Hanoi University of Business and Technology, Hanoi, Vietnam.,Nursing Office, Thien an Obstetrics and Gynecology Hospital, Hanoi, Vietnam
| | - Tien V Tran
- Department of Infectious Diseases, Vietnam Military Medical University, Hanoi, Vietnam.,Director Office, Military Hospital 103, Hanoi, Vietnam
| | - Hoang C Nguyen
- Director Office, Thai Nguyen National Hospital, Thai Nguyen, Vietnam.,President Office, Thai Nguyen University of Medicine and Pharmacy, Thai Nguyen, Vietnam
| | - Huu C Nguyen
- Director Office, E Hospital, Hanoi, Vietnam.,Department of Thoracic and Cardiovascular Surgery, E Hospital, Hanoi, Vietnam
| | - Tung H Ha
- Director Office, General Hospital of Agricultural, Hanoi, Vietnam
| | - Hung K Dao
- Director Office, Bac Ninh Obstetrics and Pediatrics Hospital, Bac Ninh, Vietnam
| | | | - Manh V Trinh
- Director Office, Quang Ninh General Hospital, Quang Ninh, Vietnam
| | - Thinh V Do
- Director Office, Bai Chay Hospital, Quang Ninh, Vietnam
| | - Hung Q Nguyen
- Director Office, Quang Ninh Obstetrics and Pediatrics Hospital, Quang Ninh, Vietnam
| | - Thao T P Nguyen
- Health Management Training Institute, Hue University of Medicine and Pharmacy, Thua Thien Hue, Vietnam.,Department of Health Economics, Corvinus University of Budapest, Budapest, Hungary
| | - Nhan P T Nguyen
- General Planning Department, Da Nang Oncology Hospital, Da Nang, Vietnam
| | - Cuong Q Tran
- Director Office, Thu Duc District Health Center, Ho Chi Minh City, Vietnam.,Faculty of Health, Mekong University, Vinh Long, Vietnam
| | - Khanh V Tran
- Director Office, Hospital District 2, Ho Chi Minh City, Vietnam
| | - Trang T Duong
- Nursing Office, Tan Phu District Hospital, Ho Chi Minh City, Vietnam
| | - Tan T Nguyen
- Department of Orthopedics, Can Tho University of Medicine and Pharmacy, Can Tho, Vietnam.,Director Office, Can Tho University of Medicine and Pharmacy Hospital, Can Tho, Vietnam
| | - Khue M Pham
- Faculty of Public Health, Hai Phong University of Medicine and Pharmacy, Hai Phong, Vietnam.,President Office, Hai Phong University of Medicine and Pharmacy, Hai Phong, Vietnam
| | - Lam V Nguyen
- Aesthetic Plastic Surgery & Skin Care Center, Can Tho University of Medicine and Pharmacy Hospital, Can Tho, Vietnam.,President Office, Can Tho University of Medicine and Pharmacy, Can Tho, Vietnam
| | - Tam T Vo
- Director Office, Trieu Phong District Health Center, Quang Tri, Vietnam
| | - Binh N Do
- Department of Infectious Diseases, Vietnam Military Medical University, Hanoi, Vietnam.,Division of Military Science, Military Hospital 103, Hanoi, Vietnam
| | - Nga H Dang
- Training and Direction of Healthcare Activity Center, Thai Nguyen National Hospital, Thai Nguyen, Vietnam.,Department of Quality Control, Thai Nguyen National Hospital, Thai Nguyen, Vietnam
| | - Thuy T Le
- Faculty of Medical Laboratory Science, Da Nang University of Medical Technology and Pharmacy, Da Nang, Vietnam.,President Office, Da Nang University of Medical Technology and Pharmacy, Da Nang, Vietnam
| | - Ngoc T Do
- Nursing Office, E Hospital, Hanoi, Vietnam
| | - Hoai T T Nguyen
- Training and Direction of Healthcare Activity Center, Kien an Hospital, Hai Phong, Vietnam
| | - Thuy T T Mai
- Nursing Office, Quang Ninh General Hospital, Quang Ninh, Vietnam
| | - Dung T Ha
- Nursing Office, Bai Chay Hospital, Quang Ninh, Vietnam
| | - Huong T M Ngo
- Nursing Office, Quang Ninh Obstetric and Pediatric Hospital, Quang Ninh, Vietnam
| | - Kien T Nguyen
- Department of Health Education, Faculty of Social Sciences, Behavior and Health Education, Hanoi University of Public Health, Hanoi, Vietnam
| | - Chyi-Huey Bai
- International Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.,School of Public Health, College of Public Health, Taipei Medical University, Taipei, Taiwan.,Department of Public Health, College of Medicine, Taipei Medical University, Taipei, Taiwan
| | - Tuyen Van Duong
- School of Nutrition and Health Sciences, Taipei Medical University, Taipei, Taiwan
| |
Collapse
|
3
|
Cardillo AG, Castellanos MM, Desailly B, Dessoy S, Mariti M, Portela RMC, Scutella B, von Stosch M, Tomba E, Varsakelis C. Towards in silico Process Modeling for Vaccines. Trends Biotechnol 2021; 39:1120-1130. [PMID: 33707043 DOI: 10.1016/j.tibtech.2021.02.004] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2020] [Revised: 02/02/2021] [Accepted: 02/03/2021] [Indexed: 01/23/2023]
Abstract
Chemical, manufacturing, and control development timelines occupy a significant part of vaccine end-to-end development. In the on-going race for accelerating timelines, in silico process development constitutes a viable strategy that can be achieved through an artificial intelligence (AI)-driven or a mechanistically oriented approach. In this opinion, we focus on the mechanistic option and report on the modeling competencies required to achieve it. By inspecting the most frequent vaccine process units, we identify fluid mechanics, thermodynamics and transport phenomena, intracellular modeling, hybrid modeling and data science, and model-based design of experiments as the pillars for vaccine development. In addition, we craft a generic pathway for accommodating the modeling competencies into an in silico process development strategy.
Collapse
Affiliation(s)
| | | | - Benoit Desailly
- Technical Research and Development, GSK, 89 Rue De L'Institut, B-1330 Rixensart, Belgium
| | - Sandrine Dessoy
- Technical Research and Development, GSK, 89 Rue De L'Institut, B-1330 Rixensart, Belgium
| | - Marco Mariti
- Technical Research and Development, GSK, 1 Via Fiorentina, 53100 Siena, SI, Italy
| | - Rui M C Portela
- Technical Research and Development, GSK, 89 Rue De L'Institut, B-1330 Rixensart, Belgium
| | - Bernadette Scutella
- Technical Research and Development, GSK, 14200 Shady Grove Rd, Rockville, MD 20850, USA
| | - Moritz von Stosch
- Technical Research and Development, GSK, 89 Rue De L'Institut, B-1330 Rixensart, Belgium; Current affiliation: Data How AG, Zürichstrasse 137, 8600 Dübendorf, Switzerland
| | - Emanuele Tomba
- Technical Research and Development, GSK, 1 Via Fiorentina, 53100 Siena, SI, Italy
| | - Christos Varsakelis
- Technical Research and Development, GSK, 89 Rue De L'Institut, B-1330 Rixensart, Belgium.
| |
Collapse
|